PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Stroke. Author manuscript; available in PMC 2010 October 1.
Published in final edited form as:
PMCID: PMC2753724
NIHMSID: NIHMS139851

Geography, Structure and Evolution of Diffusion and Perfusion Lesions in DEFUSE

Abstract

Background

The classical representation of acute ischemic lesions on MRI is a central diffusion-weighted imaging (DWI) lesion embedded in a perfusion-weighted imaging (PWI) lesion. We investigated spatial relationships between final infarcts and early DWI/PWI lesions before and after intravenous thrombolysis in DEFUSE.

Methods

Baseline and follow-up DWI and PWI lesions and 30 day FLAIR scans of 32 patients were co-registered. Lesion geography was defined by the proportion of the DWI lesion superimposed by a Tmax>4 seconds PWI lesion; type 1: >50% overlap and type 2: ≤ 50% overlap. Three-dimensional structure was dichotomized into single lesion (1 DWI and 1 PWI lesion) vs. multiple lesions. Lesion reversal was defined by the percentage of the baseline DWI or PWI lesion not superimposed by the early follow-up DWI or PWI lesion. Final infarct prediction was estimated by the proportion of the final infarct superimposed on the union of the DWI and PWI lesions.

Results

Single lesion structure with type 1 geography was present in only nine patients (28%) at baseline and 4 (12%) on early follow-up. In these patients, PWI and DWI lesions were more likely to correspond with the final infarcts. DWI reversal was greater among patients with type 2 geography at baseline. Patients with multiple lesions and type 2 geography at early follow-up were more likely to have early reperfusion.

Conclusion

Prior to thrombolytic therapy in the 3–6 hour time window, type 2 geography is predominant and associated with DWI reversal. Following thrombolysis, both type 2 geography and multiple lesion structure are associated with reperfusion.

Keywords: Brain Infarction, Magnetic Resonance, Thrombolysis

Introduction

Multimodal MRI is a technique of choice to assess patients with acute ischemic stroke.1 Diffusion-weighted imaging (DWI) demonstrates the presence of cytotoxic ischemic injury within minutes and provides an estimate of the volume of the final infarct in patients who do not experience early reperfusion.2 Perfusion-weighted imaging (PWI) provides an assessment of cerebral hemodynamics. The PWI/DWI mismatch hypothesis postulates that the difference between the acute PWI and DWI lesions provides an estimate of the ischemic penumbra. The Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE) and the Echoplanar Imaging THrombolytic Evaluation Trial (EPITHET) studies demonstrated strong associations between recanalization, reperfusion, reduced infarct growth and favorable clinical response in patients with a PWI/DWI mismatch treated with IV tPA within 3–6 hours of symptom onset.35 In these studies, mismatch was defined by a PWI lesion volume (determined by a Tmax >2 seconds delay) that was at least 20% larger than the acute DWI lesion volume.

Based on the mismatch hypothesis, an ischemic lesion composed by a central core (DWI lesion) embedded in a penumbra (DWI/PWI mismatch) has become the classical representation of acute ischemic stroke geography.6, 7 However, several studies have contested the universality of this representation. First, it has been demonstrated that PWI lesions defined by Tmax > 2 seconds delay over-estimate the volume of critically hypoperfused tissue defined by PET scan or Xe-CT, 8, 9 and employing PWI thresholds, such as a Tmax threshold of >4–6 seconds, appears to provide a more accurate estimation of penumbral tissue.2, 10 Second, early recanalization is associated with reversal of acute DWI lesions;11 however the use of ADC thresholds may help separate reversible from irreversible DWI lesions.12 Third, co-registration of acute DWI lesions with contemporaneous PET scan imaging demonstrates that DWI lesions have a heterogeneous structure and include regions of variable metabolic disruption and perfusion.13 Finally, co-registration of acute DWI/PWI lesions has shown that the most of the reversible part of the acute DWI lesion is not superimposed by a PWI lesion defined by Tmax> 2 seconds.14 Altogether, these findings emphasize the heterogeneity and complexity of the acute PWI and DWI lesions that define the anatomy of the MRI penumbra. Coregistration of sequential MRI images allows visualization of the spatial relationships between PWI and DWI lesions at different time points as well as the evolution of individual lesions between time points. Three-dimensional (3-D) analyses allow visualization of the structure of individual lesions.

To help clarify the natural history, topography and structure of PWI and DWI lesions during the first hours of acute ischemic stroke, as well as their impact on prognosis and final infarct volume and location, we used the DEFUSE dataset to examine spatial relationships between early DWI and PWI lesions and their associations with final infarct volume and location. We hypothesized that the classical single centripetal geography of the ischemic core and penumbra would evolve during the early hours following stroke onset and administration of thrombolytic therapy. Furthermore, we hypothesized that this evolution would influence the accuracy of predicting the location of the final infarct.

Methods

The inclusion criteria, MRI protocol, study design and primary results of the DEFUSE trial have been previously reported.3 In brief, patients were treated with iv tPA 3–6 hours after stroke onset and MRI scans were obtained just prior to tPA therapy, 3–6 hours after tPA, and at 30 days. For this substudy, the baseline and early follow-up DWI and PWI scans, as well the 30 day FLAIR scans, were co-registered using SPM5 (The Wellcome Department of Imaging Neuroscience, Institute of Neurology, University College London, UK). The shifts induced by coregistration were evaluated by four of the authors (MM, J-MO., MGL. and GWA). Lesion volume measured on co-registered and native maps were also compared. We obtained a mean volumetric difference of −0.12±2.98 cc and mean relative difference −0.02±9.05% suggesting that the coregistration did not significantly alter the native maps volumes.

Study Plan

Inclusion criteria

  1. A technically adequate baseline DWI and PWI.
  2. A measurable baseline DWI lesion and a baseline PWI lesion (defined by Tmax>4 seconds) >10cc.

Definitions

The geography of the mismatch was investigated by determining the proportion of DWI lesion superimposed by a Tmax>4 seconds PWI lesion. We dichotomized into 2 groups: type 1 geography was defined when >50% of DWI lesion volume superimposed with a PWI value of Tmax>4 seconds. Type 2 geography was defined as the remaining patients (≤50% of the DWI lesion volume was superimposed with Tmax>4 seconds).

The Structure of baseline DWI and PWI lesions was assessed using 3D-Doctor Software (Able software Corp, Lexington, MA USA). We classified the 3-D structure into 2 subtypes: 1) Single DWI and PWI lesion; 2) Multiple DWI and/or PWI lesions separated by at least 5 mm with the smaller lesion larger than 10% of the total lesion volume (1) or more than 10 distinct fragments separated by at least 5 mm, regardless of size (2) (cf. figure 2A). Thus the “classical” penumbral mismatch pattern was considered to have both type 1 lesion geography and single structure.

Figure 2
2a: Lesion Geography Types: Type 1: DWI/PWI overlap>50%, patients with this subtype at baseline had larger infarct volumes on 30 day FLAIR. Type 2: DWI/PWI overlap≤ 50%, patients with this subtype at baseline had smaller infarcts on 30 ...

Early DWI reversal was defined by the percentage of the acute DWI lesion with no superimposed DWI lesion on the early (3–6 hrs) follow-up study. Early DWI extension was defined as the percentage of baseline DWI lesion that extended beyond its initial location on the early follow-up study. The same definitions were applied to PWI lesions.

A favorable clinical response (FCR) was defined as a NIHSS of 0 to 1 or ≥8 points of improvement between baseline and 30 days.

We investigated the percent of final infarct on 30 day FLAIR that was predicted by the union of DWI and PWI lesions at baseline and follow-up time points. This rate was determined by the percentage of the volume of the final infarct that was superimposed on the coregistered DWI and PWI lesions at each time point.

Statistical analysis

The Mann-Whitney U test was used to compare groups defined by FCR, lesion structure and geography. The Wilcoxon signed-rank test was used to compare baseline and follow-up values. We used the Chi-square test to compare proportions and t-test to compare means and the Mc Nemar test to compare the evolution of lesion type and structure over time. The correlation between DWI and PWI evolution was estimated using Spearman correlation coefficient. An overall significance level was maintained at α<0.05. Group descriptive values are reported as median (interquartile range) unless explicitly referred as mean±standard error (SE).

Results

Baseline characteristics and Mismatch geography

Thirty-two patients met the inclusion criteria (Figure 1). Their mean ±SE age was 69±3 years old and the baseline NIHSS was 13 (9–16).

Figure 1
The flow chart demonstrates the reasons why patients were excluded from this substudy.

On baseline MRI, 12 (38%) of the patients had a type 1 geography (i.e. DWI/PWI overlap>50%) with an overlap rate of 59% (55–63) and 20 (62%) had type 2 (i.e. DWI/PWI overlap≤50%) with an overlap rate of 25% (15–37).(Figure 2a) Compared to the patients with type 2 baseline geography, baseline type 1 geography was associated with a larger median baseline DWI lesion volume; larger median baseline PWI lesion size and larger final infarct volume on 30 day FLAIR. There was no difference in mean age; median baseline NIHSS, time to MRI or time to treatment between the 2 groups. (Table 1)

Table 1
Baseline Characteristics according to lesion geography (1a), and structure (1b).

The follow-up MRI was obtained after a median delay of 5.5 hrs (4.6–6.6) following tPA therapy after baseline scan. The majority of the patients (75%) with type 1 geography at baseline had type 2 geography at 1st follow-up. In addition, virtually all of the patients (19/20) with baseline type 2 geography maintained this pattern at follow-up; p=0.021 (Figure 2B). The one exception was a patient with 49% overlap at baseline and 51% overlap at 1st follow-up. Therefore, at 1st follow-up, nearly 90% of the patients had type 2 geography and a DWI/PWI overlap rate of only 13% (6–34). The remaining 4 patients with type 1 geography had an overlap rate of 60% (52–69).

3-Dimensional Structure

Baseline DWI lesions were single in 26 (81%) patients and multiple in 6 (19%). Baseline PWI lesions were single in 23 (72%) patients and multiple in 9 (28%). (Table 1, Figure 3A)

Figure 3
Lesion Structure.

Both DWI and PWI were single lesions at baseline in 20 patients (63%). Nine patients (75%) with type 1 geography vs. 11 (55%) patients with type 2 geography had single lesion structure for both PWI and DWI, p=0.045. Overall, 9 patients (28%) had the classical mismatch pattern at baseline with both single lesion structure and type 1 geography.

Early follow-up DWI lesion structure analysis demonstrated 28 (87.5%) single lesions; 4 (12.5%) patients had multiple DWI lesions. Follow-up PWI lesion analysis demonstrated 20 (62%) patients with single lesions and 12 (38%) with multiple lesions. Both the DWI and PWI structure was a single lesion at early follow-up in 19 patients (59%). All 4 patients (100%) with follow-up type 1 geography vs. 15 (54%) with follow-up type 2 geography had single DWI and PWI lesions, p=0.128

Patients with single lesion structure at baseline had significantly larger DWI and PWI lesions. Age, NIHSS, time to treatment, time to MRI and final infarct volume on 30 day FLAIR were not statistically different. (Table 1)

Three-Dimensional imaging of combined DWI/PWI demonstrated three intertwined but distinct regions: Mismatch; DWI/PWI overlap and reperfused DWI. (Figure 3B).

Fifteen of the 20 patients who had single structure at baseline continued to have single lesions at early follow-up. Eight of the 12 with multiple lesion structure at baseline persisted to have multiple lesions on early follow-up, Mc Nemar test, p=1 (Figure 3C).

DWI and PWI evolution

DWI/PWI relationships

Fifty three percent of the baseline DWI lesion volume was not superimposed with a PWI lesion (defined by Tmax> 4 seconds). The mean Tmax value within these regions was 0.7 (SE±0.005). Eleven percent of these regions had a Tmax delay > 2 seconds and ≤4 seconds.

For the regions of DWI lesions that were superimposed with PWI lesions, the mean Tmax value was 17 (SE±39). Seventy two percent of these regions had a Tmax delay > 8 seconds.

DWI Lesion Evolution

Coregistration revealed that 39% (23–52) of the baseline DWI volume was not superimposed on the first follow-up DWI.

However, the follow-up DWI lesion typically involved additional regions that were not DWI positive at baseline. The volume of these “new” DWI regions was 56% (29–80) of the baseline DWI lesion. Because of these new areas of diffusion positivity, the early follow-up DWI volume 17cc (7–32) was larger than the baseline DWI lesion 13cc (7–35), p=0.014.

Early DWI reversal was higher among patients that had baseline type 2 geography: 46% (33–61) compared to type 1 geography: 23% (16–42), p=0.048. (Figure 4A) DWI reversal also tended to be higher among patients type 2 vs. type 1 geography at the time of early follow-up: 44% (25–58) vs. 24% (12–33), p=0.074. Early DWI extension was not associated with either baseline or follow-up geography.

Figure 4
Baseline lesion reversal according to lesion geography and structure. Relationships between baseline lesion geography (A) and structure (B) and baseline lesion reversal. Relationships between follow-up lesion geography (C) and structure (D) and baseline ...

Neither early DWI reversal nor extension was associated with baseline DWI or PWI 3-D structure.

PWI Lesion Evolution

Seventy-four percent (42–92) of the baseline PWI lesion was reversed while new regions of PWI abnormality were also noted. These “new regions” of PWI abnormality seen on the early follow-up scans typically had a volume of about 25% (8–59) of the baseline PWI lesion. The early follow-up PWI lesion volume 12.4cc (4–54), was smaller than the baseline volume of 42.6cc (18–65), p=0.003. There was a moderate correlation (R=0.558; p=0.001) between DWI and PWI reversal, however, no correlation was found between DWI and PWI extension (R=−0.179; p=0.33).

PWI reversal was higher (78% [53–92]) among patients with type 2 geography at the time of the early follow-up scan compared to those with type 1 geography at early follow-up (34% [21–43], p=0.011) (Figure 4B). PWI extension was not associated with either baseline or follow-up geography.

PWI reversal was higher among patients with multiple lesion structure (DWI or PWI) at the time of early follow-up 91% (74–95) vs. 47% (33–78), p=0.003. PWI lesion extension was less in patients who had a single baseline PWI lesion 19% (6–39) vs. 67% (37–185); p=0.024.

Clinical Outcome and DWI/PWI lesion evolution, Structure and Geography

Fifteen patients (47%) experienced a FCR while 17 (53%) did not. The occurrence of FCR was not associated with the evolution (reversal, extension) or the structure of baseline PWI or DWI lesions. Six patients (50%) with baseline type 1 geography and 9 (45%) with baseline type 2 geography had a FCR, p=1.

Final Infarct Prediction from the union of PWI and DWI (Figure 4)

Fifty-seven percent (45–69) of the final FLAIR lesion was superimposed on the union of DWI and PWI lesions from the baseline MRI. This rate was increased among patients with a baseline type 1 geography compared to patients with type 2: 68% (60–74) vs. 53% (37–63), p=0.009. Patients with a single DWI and PWI lesion at baseline had a larger proportion of final infarct superimposed on the union of the baseline DWI and PWI lesions: 65% (54–74) vs. 44% (30–56), p=0.001.

Sixty-one percent (35–72) of the final infarct was superimposed on the union of DWI and PWI lesions from the early follow-up MRI. Lesion geography on the early follow-up MRI was not associated with final infarct prediction. Patients with the single lesion structure at follow-up had a larger proportion of the final infarct superimposed on the union of the follow-up DWI and PWI lesions: 64% (58–75) vs. 51% (20–61), p=0.024.

Discussion

Our study illustrates the evolution of acute DWI and PWI lesions in acute stroke patients using objective measurements of the lesion size and location in co-registered images obtained before and after tPA administration. Our key findings are that the classical representation of the early ischemic lesion, an area of restricted diffusion embedded in a critical PWI lesion (i.e. type 1 geography with single lesion structure), is present in only about 30% of patients who are imaged 3–6 hours after symptom onset. In addition, there are substantial fluctuations in volume, location and structure of DWI and PWI lesions during the early hours after stroke onset. Furthermore, spatial relationships between DWI and PWI lesions are associated with the probability that a lesion will evolve into final infarction.

Evolution of PWI and DWI lesions

As expected, our patients demonstrated a significant reduction of the pre-treatment PWI volume 3–6 hours after tPA therapy. This reduction involved substantial PWI lesion reversal combined with modest extension into regions of normal PWI at baseline.

DWI lesions also demonstrated both regression as well as extension in the early hours following tPA administration. We have previously demonstrated that absence of recanalization and increased severity of the superimposed PWI lesion (based on Tmax delay) are associated with DWI evolution to final infarction.14 Compatible with these findings, the present study demonstrates that baseline type 2 geography (>50% of DWI with no superimposed PWI), and PWI reversal both favored early DWI lesion reversal.

Recently, we introduced the term RADAR (Reversible Acute Diffusion lesion Already Reperfused) to describe regions of acute restricted diffusion with no superimposed PWI lesion defined by Tmax delays.14 In the DEFUSE dataset these regions are associated with high rates of DWI reversal. In addition, DWI reversal in these regions is associated with favorable clinical outcomes. These findings imply that the RADAR regions comprise an important sector of the ischemic penumbra. The type 2 geography pattern was based on our prior observations that RADAR accounts for a substantial percentage of the acute DWI lesion and this pattern differs from the classical single centripetal representation of the ischemic core and penumbra. In addition, because the classical concept of the origin of a typical stroke is a single region of hypoperfusion, rather than multiple separate lesions, DWI and PWI structure (single vs. multiple lesions) was independently assessed.

We found that a single DWI and PWI lesion at baseline were more common than multiple lesions; however, the spatial relationships of the lesions typically differed from the classical concept (figure 1). The 2 approaches employed to define structure and geography shared some common findings: both type 1 geography and single lesion structure were associated with larger baseline DWI and PWI lesion volumes. Their counterparts, type 2 geography and multiple lesion structure were both associated with reperfusion. We suspect that the presence of type 2 geography prior to thrombolysis reflects spontaneous migration and/or fragmentation of acute thromboemboli. Geography and structure differed in several important ways. For example, about half (11/20) of the patients with the single lesion pattern at baseline had type 2 geography. In addition, progression from type 1 to type 2 geography on the early follow-up scan occurred in two thirds of the patients while less than one third of the patients who had single lesions at baseline evolved to the multiple lesion structure at early follow-up. These findings suggest that following tPA therapy reperfusion of the acute DWI lesion typically occurs without significant fragmentation of the ischemic lesions.

Persistence of type 1 geography and single lesion structure were both predictors that the final infarction would be substantially superimposed on the baseline PWI and DWI lesions. Several algorithms/prediction models have been proposed using both DWI and PWI values to predict the final infarct from acute DWI and PWI data.15, 16 Our findings suggest that an assessment of lesion geography and structure may improve the predictive accuracy of these models.

Study limitations

The primary limitation of our study is a small sample size. Many of the DEFUSE patients were excluded because of small or absent baseline lesions. In addition, some of the patients with the most severe strokes did not return for the 30 day follow up MRI. This limitation might contribute to the lack of relationship between structure, geography and clinical outcomes. This lack of association is intriguing since both type 1 geography and single lesion structure were associated with larger baseline DWI and PWI lesions and type 1 geography was associated with larger final infarct volumes. In addition, our results apply only to the DEFUSE time window (imaging studies performed from 4.5 to 10 hours after symptom onset) in patients who were all treated with tPA following the initial MRI. Future analyses, focused on earlier time points and untreated patients are needed to determine natural history and clarify any impact of our findings on management of acute stroke patients. Further analyses focusing on clinical outcomes with larger datasets are currently in progress.

Type 2 geography was defined on the basis of a Tmax threshold > 4 seconds. We acknowledge that Tmax is only a surrogate of CBF that does not directly reflect cerebral blood flow. DWI map generation was based on signal intensity on the b1000 map and did not directly take into account ADC thresholds that may provide a more accurate prediction of infarct core. Future analyses using ADC thresholds are also ongoing.12

Conclusion

In untreated patients imaged with MRI 3–6 hours after symptom onset, only about 30% demonstrate the classical concept of a central area of restricted diffusion surrounded by a hypoperfused penumbra. One third of the patients had multiple discrete regions of restricted diffusion or perfusion and in more than two thirds, the majority of the DWI lesion did not have a superimposed perfusion lesion. This pattern (type 2 geography) was associated with a high rate of acute DWI reversal. Following tPA therapy, type 2 geography and multiple lesion structure were associated with a high rate of reperfusion. Following thrombolysis, virtually all patients displayed type 2 geography while most maintained a single lesion structure. In addition, spatial relationships between DWI and PWI lesions were associated with the percentage of the final infarct volume that could be predicted based on the size and location of the baseline DWI and PWI lesions.

Acknowledgments

Acknowledgement and Funding

The funding for this study was provided by national institutes of health (NIH) grants RO1 NS39325, Principal Investigator, Gregory W. Albers; K24 NS044848, Principal Investigator, Gregory W. Albers; and K23 NS051372, Principal Investigator Maarten G. Lansberg. tPA was supplied at no charge by Genentech (US and Canada sites) and Boehringer Ingelheim (Belgium site). Neither Genentech, Boehringer Ingelheim, nor the NIH played a role in the design and the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation or approval of the manuscript.

Footnotes

The authors have nothing to disclose.

References

1. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: A prospective comparison. Lancet. 2007;369:293–298. [PMC free article] [PubMed]
2. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009;8:261–269. [PubMed]
3. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (defuse) study. Ann Neurol. 2006;60:508–517. [PubMed]
4. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (epithet): A placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309. [PubMed]
5. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Schlaug G, Bammer R, Marks MP, Albers GW. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (defuse) Stroke. 2008;39:2257–2263. [PMC free article] [PubMed]
6. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: Evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729–2735. [PubMed]
7. Schlaug G, Benfield A, Baird AE, Siewert B, Lovblad KO, Parker RA, Edelman RR, Warach S. The ischemic penumbra: Operationally defined by diffusion and perfusion mri. Neurology. 1999;53:1528–1537. [PubMed]
8. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, Gillard JH, Williams GB, Aigbirhio FI, Warburton EA, Ostergaard L, Baron JC. How reliable is perfusion mr in acute stroke? Validation and determination of the penumbra threshold against quantitative pet. Stroke. 2008;39:870–877. [PubMed]
9. Olivot JM, Mlynash M, Zaharchuk G, Straka M, Bammer R, Schwartz N, Lansberg MG, Moseley ME, Albers GW. Perfusion mri (tmax and mtt) correlation with xenon ct cerebral blood flow in stroke patients. Neurology. 2009;72:1140–1145. [PMC free article] [PubMed]
10. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Optimal tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40:469–475. [PMC free article] [PubMed]
11. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000;47:462–469. [PubMed]
12. Purushotham A, Mlynash M, Olivot J-M, Thijs VN, Bammer R, Kemp SM, Albers GW, Lansberg MG. Apparent diffusion coefficient distinguishes ischemic core from reversible diffusion lesions. Stroke. 2009 Abstract. [PMC free article] [PubMed]
13. Guadagno JV, Warburton EA, Jones PS, Day DJ, Aigbirhio FI, Fryer TD, Harding S, Price CJ, Green HA, Barret O, Gillard JH, Baron JC. How affected is oxygen metabolism in dwi lesions?: A combined acute stroke pet-mr study. Neurology. 2006;67:824–829. [PubMed]
14. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Relationships between cerebral perfusion and reversibility of acute diffusion lesions in defuse: Insights from radar. Stroke. 2009;40:1692–1697. [PMC free article] [PubMed]
15. Wu O, Christensen S, Hjort N, Dijkhuizen RM, Kucinski T, Fiehler J, Thomalla G, Rother J, Ostergaard L. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using mri. Brain. 2006;129:2384–2393. [PubMed]
16. Rosso C, Hevia-Montiel N, Deltour S, Bardinet E, Dormont D, Crozier S, Baillet S, Samson Y. Prediction of infarct growth based on apparent diffusion coefficients: Penumbral assessment without intravenous contrast material. Radiology. 2009;250:184–192. [PubMed]